NCT07444541 2026-04-16
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Anova Innovation Limited
Phase 1/2 Not yet recruiting
Anova Innovation Limited
Ohio State University Comprehensive Cancer Center
NRG Oncology
ImmunityBio, Inc.